Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Sifli Technologies | 2022 | Series A | $13.8M | Shanghai |
| JoyMed Technology | 2022 | Series B | $14.4M | Minhang |
| GalaxySpace | 2022 | Series D | Undisclosed | Beijing |
| Axonics Modulation Technologies | 2022 | Post Ipo Equity | $111.7M | Irvine |
| H.Extract | 2022 | Series D | Undisclosed | Qingdao Shi |
| Tianfu | 2022 | Series C | Undisclosed | Nanjing |
| Huili Bio | 2022 | Series A | $44.8M | Taizhou |
| UNIMED | 2022 | Series D | $15.0M | Beijing |
| FIT2CLOUD | 2022 | Series D | $15.7M | Beijing |
| ZHIYI TECH | 2022 | Series B | $100.0M | Xiaoshan |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 101 | Sifli Technologies | Series A | $13.8M | Shanghai, China |
| 102 | JoyMed Technology | Series B | $14.4M | Minhang, China |
| 103 | GalaxySpace | Series D | Undisclosed | Beijing, China |
| 104 | Axonics Modulation Technologies | Post Ipo Equity | $111.7M | Irvine, United States |
| 105 | H.Extract | Series D | Undisclosed | Qingdao Shi, China |
| 106 | Tianfu | Series C | Undisclosed | Nanjing, China |
| 107 | Huili Bio | Series A | $44.8M | Taizhou, China |
| 108 | UNIMED | Series D | $15.0M | Beijing, China |
| 109 | FIT2CLOUD | Series D | $15.7M | Beijing, China |
| 110 | ZHIYI TECH | Series B | $100.0M | Xiaoshan, China |
Sifli Technologies focuses on the design and application development of embedded artificial intelligence IoT platforms.
JoyMed Technology is a designer and manufacturer of medical devices.
GalaxySpace is a manufacturer of micro-satellites.
Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
H.Extract is engaged in development, production and sales of the natural plant extracts.
Tianfu provides intelligent industrial software research, development, and technical services.
Huili Bio is a next-generation synthetic biology enzyme computational design platform.
UNIMED provides integrated medical service models.
FIT2CLOUD, is a leading Multi-Cloud Management Platform provider in China.
Zhiyi Tech offers artificial intelligence technology services in the apparel industry.
Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.
Zongmu Technology is a Chinese self-driving tech firm.
Tichuang Biotechnology is an enterprise that realizes the industrialization and commercialization of cross-material types.
Medilink Therapeutics is a biotech company focusing on next-generation antibody-drug conjugate Research & development.
Jianshu is a website and mobile application that allows users to read and write Chinese and English versions of books.
Tanma SCRM is a full-process private domain traffic solution provider that helps customers improve their private domain traffic operations.
Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.
ColorTech Bio researches and develops precision molecular diagnostic equipment.
Inossem specializes in R&D and consulting services for enterprise applications.
Paixue Che is a internet learning service company providing the construction of a one-stop learning car service.
Wangdiantong is an E-commerce ERP management system that provides smart retail solutions for retailers digital transformation.
Sciwind Biosciences is a drug research and development company for metabolic diseases.
Fiture is a smart household fitness equipment brand.
Liangyihui is an online medicine and therapeutic information service platform in oncology.
Real-time financial risk management company based in Hangzhou.
Legend Capital has invested in 203 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Legend Capital's top investment sectors include Biotechnology, Health Care, Artificial Intelligence (AI), Medical Device, Health Diagnostics. The firm invests across 49 different industry categories.
Among tracked funding rounds, Wangdiantong received $312.0M in a Series D round. Legend Capital's total known invested capital is $4.9B.
Legend Capital's average investment size is $37.7M across its portfolio of 203 companies.
Recent Legend Capital portfolio additions include Sifli Technologies, JoyMed Technology, GalaxySpace, Axonics Modulation Technologies, H.Extract. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors